Re-Vana Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series B
- (Cancelled)
- Investors
-
11
Re-Vana General Information
Description
Developer of a biodegradable drug delivery platform designed to address ophthalmic conditions. The company's platform uses pre-formed, photo-crosslinked biodegradable implants to facilitate sustained intraocular release of active pharmaceutical ingredients and a patented system that involves the injection of a gel into the eye using a narrow gauge, enabling healthcare providers and pharmaceutical companies to save costs and patients to receive reduced pain, side effects, and treatment frequency.
Contact Information
Website
www.revanatx.comCorporate Office
- 63 University Road
- Belfast BT7 1NF
- Northern Ireland, United Kingdom
Corporate Office
- 63 University Road
- Belfast BT7 1NF
- Northern Ireland, United Kingdom
Re-Vana Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series B) | 28-Jul-2025 | Cancelled | Pre-Clinical Trials | |||
| 8. Later Stage VC (Series A) | 28-Nov-2022 | Completed | Pre-Clinical Trials | |||
| 7. Grant | 01-Jun-2022 | Completed | Pre-Clinical Trials | |||
| 6. Later Stage VC | 02-Jun-2020 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 01-Jan-2019 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 27-Nov-2017 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 09-Oct-2015 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 28-May-2015 | Completed | Pre-Clinical Trials | |||
| 1. University Spin-Out | 01-Jan-2015 | Completed | Startup |
Re-Vana Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A Preferred Ordinary | ||||||||
| Series 1 Preferred | ||||||||
| Ordinary | ||||||||
| Ordinary | 172,407 | $0.000117 | $4.16 | $4.16 | 1x | $4.16 | 8.22% | |
| Preference | 168,343 | $0.000117 | $4.16 | $4.16 | 1x | $4.16 | 8.03% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Re-Vana Patents
Re-Vana Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026136552-A1 | Device and methods for implant delivery | Pending | 18-Dec-2024 | ||
| WO-2026122994-A1 | Compositions for drug delivery and treatment methods | Pending | 06-Dec-2024 | ||
| WO-2026122997-A1 | Implants and compositions for drug delivery and treatment methods | Pending | 06-Dec-2024 | ||
| AU-2021291059-A1 | Biodegradable compositions and implants | Pending | 19-Jun-2020 | ||
| CA-3183343-A1 | Biodegradable compositions and implants | Pending | 19-Jun-2020 | A61K9/0051 |
Re-Vana Signals
Re-Vana Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ExSight Ventures | Venture Capital | Minority | ||
| InFocus Capital Partners | Venture Capital | Minority | ||
| Invest Northern Ireland | Limited Partner | Minority | ||
| QUBIS | Venture Capital | Minority | ||
| Visionary Venture Fund | Venture Capital | Minority |
Re-Vana FAQs
-
When was Re-Vana founded?
Re-Vana was founded in 2015.
-
Where is Re-Vana headquartered?
Re-Vana is headquartered in Belfast, United Kingdom.
-
What is the size of Re-Vana?
Re-Vana has 21 total employees.
-
What industry is Re-Vana in?
Re-Vana’s primary industry is Drug Delivery.
-
Is Re-Vana a private or public company?
Re-Vana is a Private company.
-
What is Re-Vana’s current revenue?
The current revenue for Re-Vana is .
-
How much funding has Re-Vana raised over time?
Re-Vana has raised $16.6M.
-
Who are Re-Vana’s investors?
ExSight Ventures, InFocus Capital Partners, Invest Northern Ireland, QUBIS, and Visionary Venture Fund are 5 of 11 investors who have invested in Re-Vana.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process